MB

M B Agro Prod.

Q2 FY26Fertilizers & Agrochemicals

M B Agro Prod. Q2 FY26 Results & Concall Highlights: Capex ₹400 Cr

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price170
Market cap₹7.4K Cr
P/E47.6
Updated23 Aug 2026
Read4 min read

The short version

H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization. H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.

From M B Agro Prod.'s Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization.
  • Total fertilizer production capacity will more than double to approximately 1.2 million tons by September 2026 due to expansions at Sagar (March ’26) and Dhule (September ’26).
  • Strong sales growth expected from NPK fertilizers, which contribute higher EBITDA per ton (~₹6,000) compared to SSP (~₹1,800).
  • SSP and NPK volumes sold in H1 FY '26 were 1,18,418 MT and 1,16,288 MT respectively, with strong demand projected to continue.
  • Post capacity expansions, strong performance and volume growth anticipated over the coming years.
  • New capacities expected to start contributing fully from FY '27, potentially increasing production and sales volume by about 150%.
  • Prices for SSP and NPK expected to be stable or slightly increase in H2 FY '26.

Profitability & Margins

See what M B Agro Prod. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • **Current CAPEX for FY '26:** Approximately ₹400 crore, focusing on ongoing capacity expansions.
  • **Total CAPEX for Sagar and Dhule projects:** Around ₹700 crore in fixed assets; ₹200 crore already spent, ₹200 crore expected by March 2026, balance in first half of FY '27.
  • **Funding:** Combination of debt (around ₹430 crore in term loans with most sanctions in place) and internal accruals.
  • **Expansion projects:**
  • - **Sagar (Madhya Pradesh):** Capacity expansion of 90,000 MTPA DAP/NPK and 1,65,000 MTPA sulfuric acid, to be commissioned by March 2026.
  • - **Dhule (Maharashtra):** Integrated plant with 3,30,000 MTPA DAP/NPK capacity starting September 2026.
  • **Strategic Investment:** Selected as preferred buyer for 1,30,000 MTPA Green Ammonia under SECI's SIGHT Scheme for 10 years, supporting sustainability and raw material security.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 3Mar 1
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what M B Agro Prod. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The transcript does not explicitly mention the current or expected order book or pending orders for Madhya Bharat Agro Products Limited.
  • However, it indicates strong demand in the market driven by improved monsoon, increased water reservoir levels, MSP hikes, and supportive policy environment for the upcoming Rabi season.
  • The company reported record fertilizer production and sales volumes, with robust operational performance.
  • Expansion projects at Sagar and Dhule are progressing well, expected to increase capacity significantly from FY '26 onwards.
  • The company expects steady sales and operational capacity utilization continuing into H2 FY '26 and beyond.
  • Demand for NPK products is strong, with expected sustained volumes.
  • No direct figures on order book or pending orders were disclosed in the provided transcript.

M B Agro Prod. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹395 Cr, net profit ₹60 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Sumitomo Chemical India Ltd (Q2 FY26)

    Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…

  • Chambal Fertilisers & Chemicals Ltd (Q2 FY26)

    Crop Protection and Speciality Nutrients show strong traction with a 28-29% year-on-year revenue growth and 37% growth in contribution margins; 22 new products…

  • Anya Polytech & Fertilizers Ltd (Q2 FY26)

    Packaging segment EBITDA margin is around 10%-12%, while fertilizer segment EBITDA margin is about 20%. Key concall takeaways from Anya Polytech &'s Q2 FY26…

  • Rallis India Ltd (Q2 FY26)

    Domestic business saw ~10% decline in Q2 volume; some key regions like Maharashtra and Punjab affected. Key concall takeaways from Rallis India Ltd's Q2 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were M B Agro Prod. Q2 FY26 results?

H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization. H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.

What is M B Agro Prod. share price analysis?

M B Agro Prod. currently shows a neutral. The stock trades at a P/E of 47.6 with a market cap of ₹7,381 Cr. Investors should review the full earnings analysis for detailed insights.

Is M B Agro Prod. planning capital expenditure?

Current CAPEX for FY '26:** Approximately ₹400 crore, focusing on ongoing capacity expansions.

Keep M B Agro Prod. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.